Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patent reform saga opens in Senate

Executive Summary

Work on patent reform legislation begins in the Senate June 6 with hearings by the full Judiciary Committee. Although crafted by a bipartisan group of leaders from the House and Senate Judiciary Committees, the bill remains a work in progress (1"The Pink Sheet" April 23, 2007, p. 8). Provisions limiting damage awards for patent infringement and lengthening the time frame for patent challenges remain open issues. A procedural maneuver kept the original bill intact when it moved out of the Courts, Internet and Intellectual Property Subcommittee in May, and subcommittee chairman Rep. Howard Berman, D-Calif., has pledged to reach a compromise to facilitate passage of the legislation this year (2"The Pink Sheet" May 21, 2007, p. 13)...

You may also be interested in...



PTO Says Patent Damages Should Be Left To Courts, Not Congress

Rep. Howard Berman, D-Calif., has moved patent reform legislation to the House Judiciary Committee but has not yet hammered out a compromise on the measure's damage provisions

Patent Reform Bill Gets Cool Reception From Rx Industry; Damage Cap Is Worry

A new patent reform bill introduced in Congress is likely to undergo revisions in the face of criticism from the pharmaceutical industry

'Touchless Plants' To Virtually Trained Workforces - Indian Cos Share Digitalization Tips

Despite AI and digital analytics playing an increasing role in pharma, the industry lags others globally, a recent event heard. Meanwhile, top Indian players including Sun Pharma, Cipla and others shared what is driving their initiatives, ranging from a 'touchless factory' to virtual training and lessons learned along the way.

UsernamePublicRestriction

Register

LL111799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel